Clinical efficacy of emollients in atopic dermatitis patients:
Long-lasting efficacy

S. Cestari, P. Correia, M. Feiges, J. Euzébio Junior, G. Le Dantec, C. Le Floc’h, AL. Demessant, D. Kerob

INTRODUCTION & OBJECTIVES

Atopic dermatitis (AD) is a complex, chronic relapsing skin disease characterized by underlying skin barrier porosity, microbiome disbalance, and type-2 inflammation.^1-5 Emollients are recommended in the daily management of AD of any severity.

The present study assessed the clinical benefit and local tolerance of an emollient "plus" (Emollient+) in subjects aged above 3 years with mild AD over a period of 168 days.